Morphic Announces Participation In Cowen 42nd Annual
WALTHAM, Mass., March 04, 2022 (GLOBE NEWSWIRE) -- Morphic Therapeutic (Nasdaq: MORF), a biopharmaceutical company developing a new generation of oral...
Praveen Tipirneni Chris Erdman Morphic President Annual Cowen Healthcare Conference Nasdaq Morf Morphic Therapeutic
Source: globenewswire.com